Fenoldopam Mesylate

CHEMBL1026 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
401.9 g/mol
LogP
Phase
4

This is the mesylate salt form of fenoldopam, a fast-acting injectable medication that lowers blood pressure by dilating blood vessels through dopamine receptor activation. It is used in clinical settings when rapid, controlled reduction of dangerously high blood pressure is needed.

Khối lượng phân tử

401,9000 g/mol

TPSA

135,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CS(=O)(=O)O.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1

InChI

InChI=1S/C16H16ClNO3.CH4O3S/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21;1-5(2,3)4/h1-4,7,13,18-21H,5-6,8H2;1H3,(H,2,3,4)

Molecular Formula

C17H20ClNO6S

HBD / HBA

5 / 7

Liên kết có thể quay

1

Nguyên tử nặng

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This is the mesylate salt form of fenoldopam, a fast-acting injectable medication that lowers blood pressure by dilating blood vessels through dopamine receptor activation. It is used in clinical settings when rapid, controlled reduction of dangerously high blood pressure is needed.

Yes, Fenoldopam Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1026. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 49659. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.